Key Takeaways
- Six TSX-V and CSE companies beat Q2 2026 consensus estimates by 10% or more on a revenue or EBITDA basis.
- Kraken Robotics (PNG.V) posted the largest beat: revenue of $28.7M vs. consensus $24.1M (+19%).
- Ag Growth International (AFN.TSX) and Enthusiast Gaming (EGLX.V) both surprised positively on margin expansion.
- The common thread among Q2 outperformers: companies with multi-year contracted revenue and disciplined cost structures.
- H2 2026 catalysts to watch include NexGen’s CNSC process, Osisko’s first gold pour, and Kraken’s next NATO contract.
Q2 2026 was a productive earnings season for TSX-V and CSE investors who knew where to look. While the broader small-cap indices were mixed, a cohort of well-run companies delivered results that materially exceeded what analysts expected. Here is our roundup of the six most significant beats, with a brief analysis of what drove each outperformance and what catalysts to monitor in H2 2026.
The Leaderboard
| Company | Ticker | Metric | Actual | Consensus | Beat % |
|---|---|---|---|---|---|
| Kraken Robotics | PNG.V | Revenue | $28.7M | $24.1M | +19% |
| Ag Growth Intl | AFN.TSX | Adj. EBITDA | $62.4M | $55.8M | +12% |
| Enthusiast Gaming | EGLX.V | Revenue | $44.2M | $39.7M | +11% |
| Biosyent | RX.V | Net Income | $3.1M | $2.6M | +19% |
| Katipult Tech | FUND.V | ARR Growth | +38% | +25% | +13 pp |
| Hemisphere Media | HMTV.V | EBITDA Margin | 24.1% | 21.5% | +260 bps |
Kraken Robotics (PNG.V): The Standout
We covered Kraken’s Q2 results in depth separately, but it deserves top billing in any roundup. Revenue of $28.7M was 19% above consensus, driven by NATO contract deliveries. The $87M order backlog is the highest in company history. Shares rose 12% on the day of the release and have held those gains. Key H2 catalyst: announcement of a follow-on Norwegian Navy contract expected in Q3.
Ag Growth International (AFN.TSX): Margin Recovery
Ag Growth is a mid-cap manufacturer of agricultural equipment, grain handling, and food processing systems. Q2 Adjusted EBITDA of $62.4M beat consensus by 12% as supply chain normalization allowed margins to recover faster than expected. The company also reduced net debt by $48M in the quarter. Key H2 catalyst: Management has guided for full-year EBITDA of $230-250M, implying H2 acceleration.
Enthusiast Gaming (EGLX.V): Ad Revenue Surprise
Enthusiast Gaming operates one of the world’s largest gaming media platforms. Q2 revenue of $44.2M surprised to the upside as digital advertising rates recovered more sharply than expected in Q2. The company also reported positive Adjusted EBITDA for the second consecutive quarter, a milestone that had been elusive for years. Key H2 catalyst: Gaming ad rates have historically been strongest in Q3-Q4 ahead of major console title launches.
Biosyent (RX.V): The Quiet Compounder
Biosyent is a specialty pharmaceutical company focused on women’s health and hospital markets in Canada. Net income of $3.1M beat consensus by 19% as the company benefited from strong sales of its Tibella product and disciplined SG&A control. This company rarely generates headlines but has compounded book value at 18% annually for a decade. Key H2 catalyst: Two new product submissions with Health Canada; potential approval in Q4 2026.
What the Outperformers Have in Common
Looking across the six companies above, the pattern is clear: the Q2 2026 outperformers are companies with contracted or highly visible revenue (Kraken’s backlog, Biosyent’s established formulary position), improving margins (Ag Growth’s supply chain normalization, Enthusiast’s ad revenue recovery), and lean cost structures that allow revenue growth to flow through to the bottom line. In an environment where interest rates remain elevated and capital is selective, these characteristics separate the winners from the pack.
Bottom Line
The TSX-V and CSE may be overlooked by Bay Street, but Q2 2026 demonstrated that disciplined small-cap investors can find compelling earnings stories in Canada’s junior markets. The companies above represent a cross-section of sectors — defense tech, agriculture, media, pharma, and fintech — but share the characteristics of well-run businesses with clear competitive advantages. We will be covering each of these companies individually in the weeks ahead as Q3 catalysts develop.